MUSTANG BIO INC (MBIO)

US62818Q2030 - Common Stock

0.214  0 (-1.92%)

After market: 0.2159 +0 (+0.89%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
21.43M50.73M76.16M66.72M56.81M
Research and Development
13.90M39.14M61.25M53.51M45.60M
Selling, General, and Administrative Expenses
6.54M9.69M12.21M11.02M9.51M
Operating Income
-21.43M-50.73M-76.16M-66.72M-56.81M
Interest Income/Expense
240.00K-3.26M-2.67M350.00K-3.21M
Other Income/Expense
313.00K917.00K1.30MN/AN/A
Non Recurring Items
N/A1.47MN/AN/AN/A
Income Before Taxes
-23.42M-51.60M-77.53M-66.37M-60.02M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-23.42M-51.60M-77.53M-66.37M-60.02M
EBITDA
-20.54M-48.87M-73.44M-64.55M-55.13M
 
Per Share Data
EPS Diluted Total Ops
-1.71-6.00-11.24-11.33-17.09
Non GAAP EPS
N/A-6.32-11.25-3.84-1.15
 
Statistics

All data in USD

Charts